Product Information
CARVEDILOL 12.5 MG TABLET is a generic product labeled by Sandoz Inc., priced at $0.0210 per EA under NDC 00781522301. Its NADAC has been published 652 times since Nov 28, 2013.
FDA first approved this application on Sep 5, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The Low Outlier badge above means this manufacturer's average price in the Carvedilol market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5 mg/1
Manufacturer
Sandoz Inc.NDC
00781522301
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
5/20/2026
Active Ingredients
CARVEDILOLApproval Type
Generic (ANDA)
FDA Application
ANDA078227FDA Approved
9/5/2007
TE Code
AB
On Market Since
9/5/2007
Pharmacological Classes
Price Statistics
The NADAC for CARVEDILOL 12.5 MG TABLET has been published 652 times since Nov 28, 2013, and over the history we have for it it has declined 36.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0210 per EA |
|---|---|
| All-time high | $0.0359 (Dec 16, 2015) |
| All-time low | $0.0184 (Nov 20, 2024) |
| 52-week high | $0.0217 |
| 52-week low | $0.0209 |
| Median price | $0.0252 |
| Average price | $0.0261 |
| Largest weekly change | +19.9% (Nov 18, 2015) |
| Weeks tracked | 652 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
+0.7%
1Y
-3.0%
3Y
-5.9%
5Y
-17.8%
All
-36.3%
Last surveyed May 20, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CARVEDILOL 12.5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL 12.5 MG TABLET, manufactured by Sandoz Inc., is $0.0210 per EA (NDC 00781522301), effective May 20, 2026.
How has the price of CARVEDILOL 12.5 MG TABLET changed over time?
Over the history we have for it, the NADAC for CARVEDILOL 12.5 MG TABLET has declined 36.3%. It has been tracked across 652 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CARVEDILOL 12.5 MG TABLET?
Since Nov 28, 2013, the NADAC for CARVEDILOL 12.5 MG TABLET has ranged from a low of $0.0184 (Nov 20, 2024) to a high of $0.0359 (Dec 16, 2015), with a median of $0.0252 per EA.
Are there cheaper alternatives to CARVEDILOL 12.5 MG TABLET?
9 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CARVEDILOL 12.5 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CARVEDILOL 12.5 MG TABLET?
CARVEDILOL 12.5 MG TABLET (NDC 00781522301) is labeled by Sandoz Inc., and CMS classifies it as a generic product.